Solid Biosciences Inc.

Historical 13F Holders

Symbol
SLDB
CUSIP
83422E105
All holders as of
Q1 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 83422E105 since 12/18/2024, largest first.

Filer % of Class Filed
RA Capital Management, L.P. 13D/A
9.9% 2/21/2025
Event 2/19/2025
BCLS SB Investco, LP 13D/A
8.8% 3/10/2026
Event 3/6/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Camber Capital Management LP 13G/A
0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q1 7 5.93 k $43.1k
2025 Q4 5 1.37 k $7.73k
2025 Q3 5 12.5 k $77.1k
2025 Q2 4 996 $4.85k
2025 Q1 3 478 $1.77k
2024 Q4 1 7.00 $28
2024 Q3 1 7.00 $49
2024 Q2 1 7.00 $40
2024 Q1 1 6.00 $80
2023 Q4 1 6.00 $37
2023 Q3 1 6.00 $15
2023 Q2 2 72.0 $377
2023 Q1 2 72.0 $341
2022 Q4 2 10.8 k $58.1k
2022 Q3 62 63.5 M $33.4M
2022 Q2 69 64.2 M $39.5M
2022 Q1 78 69.3 M $83.2M
2021 Q4 83 75.6 M $132M
2021 Q3 94 77.0 M $184M
2021 Q2 94 80.2 M $293M
2021 Q1 108 79.1 M $438M
2020 Q4 78 54.6 M $414M
2020 Q3 62 25.5 M $52.5M
2020 Q2 67 26.8 M $79.1M
2020 Q1 72 19.6 M $46.9M
2019 Q4 72 19.9 M $88.5M
2019 Q3 70 32.1 M $332M
2019 Q2 75 21.4 M $129M
2019 Q1 77 17.1 M $157M
2018 Q4 78 24.2 M $648M
2018 Q3 77 18.6 M $879M
2018 Q2 64 17.3 M $617M
2018 Q1 58 15.9 M $119M